These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1384958)

  • 41. Therapeutic anti-tumor response induced with epitope-pulsed fibroblasts genetically engineered for B7.1 expression and IFN-gamma secretion.
    Kim TS; Chung SW; Kim SH; Kang SN; Kang BY
    Int J Cancer; 2000 Aug; 87(3):427-33. PubMed ID: 10897050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Augmentation of antitumor immunity by genetically engineered fibroblast cells to express both B7.1 and interleukin-7.
    Kim TS; Chung SW; Hwang SY
    Vaccine; 2000 Jun; 18(25):2886-94. PubMed ID: 10812232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor antigen-specific immunization of bone marrow transplantation donors as adoptive therapy against established tumor.
    Hornung RL; Longo DL; Bowersox OC; Kwak LW
    J Natl Cancer Inst; 1995 Sep; 87(17):1289-96. PubMed ID: 7544833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes.
    Hjálmsdóttir Á; Bühler C; Vonwil V; Roveri M; Håkerud M; Wäckerle-Men Y; Gander B; Johansen P
    Mol Pharm; 2016 Feb; 13(2):320-9. PubMed ID: 26704885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of antigen expression from plasmid DNA in tumor-free and antigen-expressing tumor-bearing mice.
    Guan X; Guan X; Nishikawa M; Nishikawa M; Li H; Li H; Rei T; Rei T; Takahashi Y; Takahashi Y; Takakura Y; Takakura Y
    Hum Vaccin Immunother; 2012 Feb; 8(2):194-200. PubMed ID: 22426379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incorporation of polyinosine-polycytidylic acid enhances cytotoxic T cell activity and antitumor effects by octaarginine-modified liposomes encapsulating antigen, but not by octaarginine-modified antigen complex.
    Nakamura T; Moriguchi R; Kogure K; Harashima H
    Int J Pharm; 2013 Jan; 441(1-2):476-81. PubMed ID: 23159346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclophosphamide eradicates murine immunogenic tumor coding for a non-self-antigen and induces antitumor immunity.
    Salem ML; El-Naggar SA; Mahmoud HA; Elgharabawy RM; Bader AM
    Int J Immunopathol Pharmacol; 2018; 32():2058738418796591. PubMed ID: 30270681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monophosphoryl lipid A enhances specific CTL induction by a soluble protein antigen entrapped in liposomes.
    Zhou F; Huang L
    Vaccine; 1993; 11(11):1139-44. PubMed ID: 8249434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An improved method of loading pH-sensitive liposomes with soluble proteins for class I restricted antigen presentation.
    Zhou F; Rouse BT; Huang L
    J Immunol Methods; 1991 Dec; 145(1-2):143-52. PubMed ID: 1765645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of pH-sensitive fusogenic polymer-modified liposomes co-loaded with antigen and α-galactosylceramide as an anti-tumor vaccine.
    Okazaki S; Iwasaki T; Yuba E; Watarai S
    J Vet Med Sci; 2018 Feb; 80(2):197-204. PubMed ID: 29311431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A liposome-based antigen delivery system using pH-sensitive fusogenic polymers for cancer immunotherapy.
    Yuba E; Harada A; Sakanishi Y; Watarai S; Kono K
    Biomaterials; 2013 Apr; 34(12):3042-52. PubMed ID: 23374704
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dendritic cells loaded with exogenous antigen by electroporation can enhance MHC class I-mediated antitumor immunity.
    Kim KW; Kim SH; Jang JH; Lee EY; Park SW; Um JH; Lee YJ; Lee CH; Yoon S; Seo SY; Jeong MH; Lee ST; Chung BS; Kang CD
    Cancer Immunol Immunother; 2004 Apr; 53(4):315-22. PubMed ID: 14685778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vaccination with OVA-bound nanoparticles encapsulating IL-7 inhibits the growth of OVA-expressing E.G7 tumor cells in vivo.
    Toyota H; Yanase N; Yoshimoto T; Harada M; Kato Y; Mizuguchi J
    Oncol Rep; 2015 Jan; 33(1):292-6. PubMed ID: 25394516
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liposome-mediated delivery stimulates a class I-restricted cytotoxic T cell response to soluble antigen.
    Lopes LM; Chain BM
    Eur J Immunol; 1992 Jan; 22(1):287-90. PubMed ID: 1730255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. Priming in vitro and in vivo for class I-restricted recognition of soluble antigen.
    Chen W; Carbone FR; McCluskey J
    J Immunol Methods; 1993 Mar; 160(1):49-57. PubMed ID: 7680698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD8+ T-cell mediated tumor protection by Pseudomonas exotoxin fused to ovalbumin in C57BL/6 mice.
    Becerra JC; Arthur JF; Landucci GR; Forthal DN; Theuer CP
    Surgery; 2003 Apr; 133(4):404-10. PubMed ID: 12717358
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor growth control using red blood cells as the antigen delivery system and poly(I:C).
    Banz A; Cremel M; Mouvant A; Guerin N; Horand F; Godfrin Y
    J Immunother; 2012 Jun; 35(5):409-17. PubMed ID: 22576346
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies on the immunogenicity of an endogenously processed protein antigen in mice.
    Mowat AM; Donachie AM
    Immunol Lett; 1991 Mar; 27(3):243-9. PubMed ID: 2060976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytotoxic T-cell response and in vivo protection against tumor cells harboring activated ras proto-oncogenes.
    Fenton RG; Taub DD; Kwak LW; Smith MR; Longo DL
    J Natl Cancer Inst; 1993 Aug; 85(16):1294-302. PubMed ID: 8340941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. pH-sensitive polymer-liposome-based antigen delivery systems potentiated with interferon-γ gene lipoplex for efficient cancer immunotherapy.
    Yuba E; Kanda Y; Yoshizaki Y; Teranishi R; Harada A; Sugiura K; Izawa T; Yamate J; Sakaguchi N; Koiwai K; Kono K
    Biomaterials; 2015 Oct; 67():214-24. PubMed ID: 26222284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.